Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

KalVista Pharmaceuticals (KALV) Other Gross PP&E Adjustments (2017 - 2025)

KalVista Pharmaceuticals' Other Gross PP&E Adjustments history spans 11 years, with the latest figure at -$3.1 million for Q2 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 33.38% to -$3.1 million in Q2 2025 year-over-year; TTM through Apr 2025 was -$3.1 million, a 33.38% increase, with the full-year FY2025 number at -$3.1 million, up 33.38% from a year prior.
  • Other Gross PP&E Adjustments hit -$3.1 million in Q2 2025 for KalVista Pharmaceuticals, up from -$9.5 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for KALV hit a ceiling of -$1.9 million in Q1 2021 and a floor of -$9.8 million in Q4 2024.
  • Historically, Other Gross PP&E Adjustments has averaged -$6.6 million across 4 years, with a median of -$8.3 million in 2024.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 249.75% in 2021 and later skyrocketed 33.38% in 2025.
  • Tracing KALV's Other Gross PP&E Adjustments over 4 years: stood at -$2.4 million in 2021, then tumbled by 270.6% to -$9.0 million in 2023, then decreased by 5.25% to -$9.5 million in 2024, then surged by 67.11% to -$3.1 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for KALV at -$3.1 million in Q2 2025, -$9.5 million in Q4 2024, and -$9.8 million in Q4 2024.